Science Explorer Interactive view Map
Company · Sydney · Australia

Pharmaxis (Australia)

pharmaxis.com.auROR OpenAlex
Research works
32
▼ 20% vs 2013–17
Citations
1.1k
32.5 per fractional work
Top-10% rate
40.4%
record average 16.5%
Open access
51%
world 28%

Not ranked overall: Pharmaxis (Australia) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.40× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.73× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 1.90× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 16.27× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.41× its world share, 0 worksChemistryMathematics: 0.65× its world share, 0 worksMathematicsHealth Professions: 1.45× its world share, 0 worksHealth ProfessionsMedicine: 2.65× its world share, 2 worksMedicineEconomics, Econometrics and Finance: 1.79× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 16.3×. Every wedge is a field page.

Which keywords describe research at Pharmaxis (Australia)?

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Metabolic Engineering, Nanoparticles, Lysyl Oxidase, Methanotrophy, Inhaler Devices, Pulmonary Drug Delivery and Pharmaceutical Industry.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 29 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 29 words, with their numbers
  1. Inflammation5▲ 6.0×16 topics
  2. Metabolic Engineering4▲ 97×2 topics
  3. Nanoparticles4▲ 8.8×3 topics
  4. Lysyl Oxidase4▲ 1187×1 topic
  5. Methanotrophy4▲ 1187×1 topic
  6. Inhaler Devices4▲ 360×1 topic
  7. Pulmonary Drug Delivery4▲ 360×1 topic
  8. Epidemiology2▲ 1.35×9 topics
  9. Pharmaceutical Industry2▲ 137×2 topics
  10. Oxidative Stress2▲ 2.8×5 topics
  11. Treatment2▲ 4.0×6 topics
  12. Cardiovascular Disease2▲ 4.4×6 topics
  13. Clinical Trials2▲ 8.1×6 topics
  14. Cystic Fibrosis2▲ 62×2 topics
  15. Pulmonary Infections2▲ 92×2 topics
  16. Bronchiectasis2▲ 177×1 topic
  17. CFTR2▲ 177×1 topic
  18. Quality of Life1▲ 3.1×6 topics
  19. Antioxidant1▲ 6.0×4 topics
  20. Publication Bias1▲ 78×2 topics
  21. Asthma1▲ 29×2 topics
  22. Genetics1▲ 4.7×2 topics
  23. Allergic Diseases1▲ 43×1 topic
  24. Conflict of Interest1▲ 259×1 topic
  25. Diabetes1▲ 6.7×3 topics
  26. Eosinophils1▲ 43×1 topic
  27. Research Outcome1▲ 259×1 topic
  28. Thrombosis1▲ 16×2 topics
  29. Chronic Kidney Disease1▲ 13×4 topics

Which research topics does Pharmaxis (Australia) publish most on?

By volume in 2022–2025: Microbial metabolism and enzyme function, Occupational and environmental lung diseases, Health Systems, Economic Evaluations, Quality of Life and Pharmaceutical industry and healthcare.

Microbial metabolism and…0Microbial metabolism and enzyme function: 0 fractional worksOccupational and environ…0Occupational and environmental lung diseases: 0 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 0 fractional worksPharmaceutical industry and healthcare: 0 fractional worksKruppel-like factors res…0Kruppel-like factors research: 0 fractional worksChronic Myeloid Leukemia Treatments: 0 fractional worksMedical and Biological Ozone Research: 0 fractional worksCoagulation, Bradykinin,…0Coagulation, Bradykinin, Polyphosphates, and Angioedema: 0 fractional worksHealthcare cost, quality, practices: 0 fractional worksBiochemical Acid Research Studies: 0 fractional works
Molecular BiologyPulmonary and Respiratory MedicineEconomics and EconometricsPharmacology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Microbial metabolism and enzyme function Molecular Biology 0 works
  2. 2 Occupational and environmental lung diseases Pulmonary and Respiratory Medicine 0 works
  3. 3 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
  4. 4 Pharmaceutical industry and healthcare Pharmacology 0 works
  5. 5 Kruppel-like factors research Molecular Biology 0 works
  6. 6 Chronic Myeloid Leukemia Treatments Hematology 0 works
  7. 7 Medical and Biological Ozone Research Pharmacology 0 works
  8. 8 Coagulation, Bradykinin, Polyphosphates, and Angioedema Genetics 0 works
  9. 9 Healthcare cost, quality, practices General Health Professions 0 works
  10. 10 Biochemical Acid Research Studies Biochemistry 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available51.4%not open48.6%

World: 28% of research is openly available.

with international co-authors39.4%domestic only60.6%

World: 19% is written across borders.

How has Pharmaxis (Australia)'s research output changed?

Output in 2018–2022 was 20% lower than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Sydney

All research institutions in Sydney

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.